Jacobs Levy Equity Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Jacobs Levy Equity Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-158,455	Closed	-$632K	–	1149
2021 Q3	$632K	Buy	158,455 +27,155	+21%	+$108K	﹤0.01%	832
2021 Q2	$562K	Sell	131,300 -123	-0.1%	-$527	﹤0.01%	843
2021 Q1	$557K	Sell	131,423 -61,975	-32%	-$341K	﹤0.01%	849
2020 Q4	$750K	Buy	193,398 +38,748	+25%	+$166K	0.01%	786
2020 Q3	$623K	Buy	154,650 +48,004	+45%	+$199K	0.01%	751
2020 Q2	$454K	Buy	106,646 +26,428	+33%	+$161K	﹤0.01%	808
2020 Q1	$337K	Buy	80,218 +38,563	+93%	+$244K	﹤0.01%	813
2019 Q4	$164K	Buy	+41,655	New	+$246K	﹤0.01%	953

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management's LJPC Position: Q4 2021 in Review

Jacobs Levy Equity Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 158,455 shares — an estimated $632K sold.

Jacobs Levy Equity Management first reported a position in LJPC in Q4 2019 and held it in 8 quarters. The position peaked at $750K in Q4 2020. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

Jacobs Levy Equity Management reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
Jacobs Levy Equity Management sold 158,455 La Jolla Pharmaceutical Company shares in Q4 2021, an estimated $632K.
Jacobs Levy Equity Management first reported a position in La Jolla Pharmaceutical Company in Q4 2019 and held it in 8 quarters.
Jacobs Levy Equity Management's La Jolla Pharmaceutical Company position peaked at $750K in Q4 2020.
44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.